Note 8 - Segment Information and Dissaggregated Revenue

3 Months Ended

Sep. 30, 2018

Segment Reporting Disclosure [Text Block]

Note

Segment Information and Disaggregated Revenue

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into

three

reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the

three

months ended

September 30, 2018

and

2017

were

$1,239

and

$1,658,

respectively.

Financial information relating to the

three

months ended

September 30, 2018

and

2017

operations by business segment and disaggregated revenues are as follows:

			Sales, Net						Segment
			U.S.		International				Gross				Capital
			Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract	2018	$	8,655	$	1,197	$	9,852	$	1,083	$	65	$	18
Manufacturing	2017		7,822		1,583		9,405		835		74		93
Branded Proprietary	2018		71		7		78		21		-		-
Products	2017		19		11		30		32		1		13
Other Nutraceutical	2018		339		35		374		115		1		-
Businesses	2017		271		64		335		138		-		1
Total	2018		9,065		1,239		10,304		1,219		66		18
Company	2017		8,112		1,658		9,770		1,005		75		107

	Total Assets as of
	September 30,		June 30,
	2018		2018
Contract Manufacturing	$	17,339	$	12,200
Branded Proprietary Products		665		543
Other Nutraceutical Businesses		1,715		1,825
Total Company	$	19,724	$	14,568